A clinical trial of liver SPIO-MRI in the diagnosis of nonalcoholic steatohepatitis

A clinical trial of liver SPIO-MRI in the diagnosis of nonalcoholic steatohepatitis - Liver SPIO-MRI in NASH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000788

Enrollment

Registered

2012-04-01

Start date

2006-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic steatohepatitis

Interventions

Duration: three years Patients, who will undergo liver biopsy for clinical suspicion of nonalcoholic steatohepatitis (NASH), will be enrolled in this study. The patients will take liver SPIO-MRI exam

NASH&quot

and &quot

not NASH&quot

, and to assess their correlations with the clinicopathological variables.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients, who will undergo liver biopsy for clinical suspicion of nonalcoholic steatohepatitis, and from whom we can obtain informed consents.

Exclusion criteria

Exclusion criteria: The patients who have no normal judgement ability for infomed consent. The patients who have past history of allergy to Resovist, contrast agent for liver SPIO-MRI, or kind medicine. The patients who are pregnant or will doublfully be pregnant. The patients who the treating doctors decide are inadequate to enrollment to this trial.

Design outcomes

Primary

Measure	Time frame
Liver imaging in SPIO-MRI	—

Countries

Japan

Contacts

Public ContactKengo Tomita

Department of Internal Medicine, Keio University School of Medicine Division of Gastroenterolgy and Hepatology

kengo@boreas.dti.ne.jp03-3353-1211(ext62384)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026